Following a pitch process, Fox Kalomaski Crossing, the integrated creative communications company, has been appointed by Hisamitsu Pharmaceutical to develop a multi-media advertising campaign to support the UK launch of Salonpas® pain relief patches.
Already a huge success in other parts of the world, Salonpas® is pain relief medicine for muscular pain in a patch. This is a new kind of pain relief solution for the UK consumer, where the analgesic market is currently dominated by tablets, creams and gels, and by non-medicine heating pads.
A new national TV campaign, targeted at muscular pain sufferers looking for a treatment that’s effective and complements their lifestyles, will break at the start of February 2013. The campaign will be deployed across all major terrestrial and satellite channels.
Robert Thackery, FKC’s Strategy Director, explains, “We are extremely excited to be working with Hisamitsu and to be promoting Salonpas®. Hisamitsu Pharmaceutical is the global technology leader in transdermal pain-relief patches that deliver anti-inflammatory medicine directly to the point of pain. Salonpas® has already achieved huge success in other markets around the world. It is a clinically proven medicine that provides long-lasting pain relief in a format that people in the UK will not have seen before. Our aim is to build a memorable brand communication property for the brand using our consumer insights on how muscular pain compromises everyday life.”
Hiroyuki Takada Sales & Marketing General Manager of Hisamitsu UK, commented, “We have appointed Fox Kalomaski Crossing following a pitch and consumer research into their recommended advertising and communication platform. As a result we are confident that FKC will deliver a highly successful launch for the Salonpas® brand in the UK.”